January 19, 2025

ADA reaffirms commitment to oral health through editorial

The ADA is encouraging federal officials to consider the importance of oral health and its effect on overall health.   

ADA News

January 17, 2025

Risks of Preterm Birth, Low Birth Weight, Birth Defects Among Children Born to Young Men With Cancer

Investigators have explored the risk of having children who experience preterm birth, low birth weight, and birth defects among male adolescents and young adults with cancer.

The ASCO Post

January 17, 2025

Patient Care Declines After PE Acquisition

A recent study reveals that patient-reported care experience declined significantly at hospitals acquired by private equity firms, highlighting the potential impact of private equity acquisitions on patient care.

Conexiant

January 17, 2025

Study links dry eye with traffic-related air pollution

Short-term exposure to traffic-related air pollutants was linked with a risk of dry eye disease outpatient visits.

Optometric Management

January 17, 2025

AACR Expresses Sincere Appreciation After NIH Director Monica M. Bertagnolli, MD, Steps Down

The American Association for Cancer Research (AACR) expressed its gratitude to Monica M. Bertagnolli, MD, for her outstanding service to the United States during her 14-month tenure as Director of the...

The ASCO Post

January 16, 2025

Vertigo, Emesis, Auditory Impairment: What's Your Diagnosis?

A patient presents with sudden-onset right-sided otalgia accompanied by vertigo, emesis, and auditory impairment. Your otoscope reveals an unexpected finding. What's your diagnosis?

Conexiant

January 16, 2025

Algorithm Improves Diagnosis of Uterine Lesions

"The preoperative 3-class diagnostic algorithm and risk class system can stratify women according to risk of malignancy."

Conexiant

January 16, 2025

Adjuvant T-DM1 in Patients With HER2-Positive Breast Cancer: Long-Term Results of the KATHERINE Trial

Adjuvant treatment with an antibody-drug conjugate (ADC) may improve survival in patients with high-risk HER2-positive breast cancer and residual invasive disease.

The ASCO Post

January 16, 2025

Study: Baloxavir Shows Promise in Nonsevere Influenza

Baloxavir probably reduced risk of hospital admission for high-risk patients and may reduce time to alleviation of symptoms, without increasing adverse events related to treatment in patients with nonsevere influenza," finds comprehensive network meta-analysis of 73 trials involving 34,332 participants.

Conexiant